News | Contrast Media | July 12, 2016

ACR Manual on Contrast Media Addresses FDA Gadolinium Safety Concerns

Updated resource for radiologists guides safe, effective use of contrast media in daily practice

gadolinium, ACR Manual on Contrast Media, update, FDA safety concerns

July 12, 2016 — The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement addressing the U.S. Food and Drug Administration (FDA) safety communication on use of gadolinium-based contrast agents for magnetic resonance imaging (MRI).

Gadolinium-based contrast agents are administered to approximately 30 million patients every year to improve the diagnostic accuracy of MR examinations. Researchers have found that gadolinium-based contrast agents may leave deposits in the brain, bone and other organs. “If the decision is made to use a gadolinium-based contrast agent for an MRI study for an individual patient, multiple factors need to be considered … including diagnostic efficacy, relaxivity, rate of adverse reactions, dosing/concentration and propensity to deposit in more sensitive organs, such as the brain,” notes a joint statement from the ACR and the American Society of Neuroradiology (ASNR).

“This vital guide for radiologists enhances the safe and effective use of contrast media in daily practice to ensure optimal patient care,” said Jacqueline Bello, M.D., FACR, chair of the ACR Commission on Quality and Safety. “The timely inclusion of the ACR and ASNR joint statement addresses questions posed by many radiology professionals about gadolinium-based contrast agents in the previous months,” she added.

“Reviews from radiologists show that this reference on contrast media is a practical and valuable resource in support of the millions of radiological examinations that may be assisted by intravascular contrast media annually,” said James H. Ellis, M.D., FACR, chair of the ACR Committee on Drugs and Contrast Media. He noted that the manual continues to be available for free as a frequently updated downloadable document on the ACR website.

Version 10.2 of the resource for using contrast media in diagnostic imaging includes:

  • An updated footnote in “Metformin,” concerning the FDA’s April 2016 guidance on patients who take this medication and who receive iodinated contrast media;
  • Information and new references about intra-osseous injection in “Injection of Contrast Media”; and
  • The addition of a document version history, so users may track changes from version to version.

 

Related Gadolinium Safety Concern Articles

Gadolinium May Remain in Brain after Contrast MRI

MRIs During Pregnancy Are Safe, But Gadolinium Scans May Increase Risk to Fetus

Study Finds No Association Between Gadolinium Contrast and Nervous System Disorder

Even High Doses of Gadolinium-Based Contrast Agents Doesn't Cause NSF

 

For more information: www.acr.org

Related Content

GE Healthcare Highlights New Signa Premier MRI System at ISMRM 2017
News | Magnetic Resonance Imaging (MRI) | April 27, 2017
GE Healthcare will showcase Signa Premier, its U.S. Food and Drug Administration (FDA) 510(k)-pending, wide bore 3.0T...
Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017
News | Magnetic Resonance Imaging (MRI) | April 24, 2017
April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will demons
Philips Showcases Newest MR-based Innovations at ISMRM 2017
News | Magnetic Resonance Imaging (MRI) | April 24, 2017
Philips announced that it will feature the company’s latest magnetic resonance (MR) solutions and neurology-focused...
SyntheticMR Myelination Quantification Feature Receives CE Mark
News | Magnetic Resonance Imaging (MRI) | April 19, 2017
April 19, 2017 — REMyDI (Rapid Estimation of Myelin for Diagnostic Imaging), first introduced by SyntheticMR AB at th
3-D-printed Model of Stenotic Intracranial Artery Enables Vessel-Wall MRI Standardization
News | 3-D Printing | April 18, 2017
April 18, 2017 — A collaboration between stroke neurologists at the Medical University of South Carolina (MUSC) and b
New MRI Technique Shows Effectiveness of Cystic Fibrosis Drug

Image courtesy of Toshiba Medical.

News | Magnetic Resonance Imaging (MRI) | April 14, 2017
Researchers from the University of Missouri School of Medicine have developed an imaging technique using a specific...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
fMRI, functional MRI, patience, imagination, neuroscience, Psychological Science journal, clinical study
News | Neuro Imaging | April 06, 2017
By using functional magnetic resonance imaging (fMRI) to look inside the brain, neuroscientists at the University of...
News | Prostate Cancer | April 04, 2017
Profound Medical Corp. announced that the first TULSA-PRO patient paid procedure has been successfully conducted at the...
Analogic, bkFusion, bk3000, MRI-ultrasound fusion, prostate biopsy, EAU 2017
News | Biopsy Systems | March 30, 2017
March 30, 2017 — Analogic Corp.
Overlay Init